MedTrace Logo

Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)

NCT00321503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2013-12-09

No results posted yet for this study

Summary

This study is a test of how well a new FDA-approved device is for diagnosing a condition known as laryngopharyngeal reflux (LPR). The device, which measures pH of the air in the upper throat, will be compared to several other methods for diagnosing laryngopharyngeal reflux.

Conditions

  • Laryngopharyngeal Reflux

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Respiratory Technology Corporation

    collaborator INDUSTRY

  • Emory University

    lead OTHER

Principal Investigators

  • Adam Klein, MD · Dept of Otolaryngology

  • Michael M Johns, MD · Dept of Otolaryngology / Director of Emory Voice Center

  • Leena Khaitan, MD, MPH · Dept of Surgery

  • Justin S Golub, BA · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00321503 on ClinicalTrials.gov